Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Plos One|July 20, 2016
Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast CancerKaylyn L Devlin, Tiffany Sanford, Lauren M Harrison, et al.Plos One|May 9, 2014
Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent mannerAlison E Harvey, Laura M Lashinger, Drew Hays, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|October 31, 2008
Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis linkStephen D Hursting, Laura M Lashinger, Karrie W Wheatley, et al.Cancer Biology & Therapy|October 13, 2004
Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenograftsChandrajit P Raut, Steffan Nawrocki, Laura M Lashinger, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 28, 2013
Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-ILaura M Lashinger, Lauren M Harrison, Audrey J Rasmussen, et al.Diabetes|January 11, 2015
Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated MechanismsVincenza Cifarelli, Laura M Lashinger, Kaylyn L Devlin, et al.Cancer Prevention Research (Philadelphia, Pa.)|May 20, 2011
Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancerLaura M Lashinger, Lauren M Malone, Graham W Brown, et al.Cancers|December 24, 2021
β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal AdenocarcinomaMichael F Coleman, Kristyn A Liu, Alexander J Pfeil, et al.Cancer & Metabolism|September 22, 2016
Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumorsLaura M Lashinger, Ciara H O'Flanagan, Sarah M Dunlap, et al.Neoplasia (New York, N.Y.)|January 26, 2016
Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor ActivityYoussef W Naguib, Dharmika Lansakara-P, Laura M Lashinger, et al.Pageof 3